MB Quest, a member of the Pharm-Olam Group, has conducted clinical trials in Russia since 1997. MB Quest has local offices in the capital cities of Russia (Moscow), Ukraine (Kiev), Belarus (Minsk), and Georgia (Tbilisi) in addition to regional offices in St. Petersburg and Novosibirsk, Russia. The metro areas of these cities have a combined population of over 18 million people. All of our local staff are fluent in English, in addition to their native language.
Russia and the neighboring states of Ukraine, Belarus, and Georgia are one of the fastest growing clinical research areas in the world. With major population centers and large medical institutions, patient access and motivation to participate are excellent. The centralized healthcare system in the region allows for established databases of patients with diagnosed medical needs — leading to faster study completion.
Benefits of conducting trials these areas include:
- Fast regulatory approval
- Low patient relocation rates
- Experienced investigators who provide high patient recruitment and retention rates
- Academic centers and specialized hospitals for all therapeutic areas
- Opinion leaders in each therapeutic area
- Western medical techniques/processes
FDA Inspections in Russia
Source: http://www.fda.gov/cder/regulatory/investigators/cliil.zip (May 5, 2008)
(Western Europe includes UK, France, Belgium, Spain, Germany, Italy, Switzerland, Netherlands)